Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services
Select solutions (2)
Active Filters (2)
Clear All
1 - 12 of 22 Results
Sort by:
Best Match

The T-SPOT.CMV test assesses a patient’s level of anti-CMV cell-mediated immunity
Explore how Cytomegalovirus (CMV) cell-mediated immunity and the T-SPOT.CMV test can enhance understanding of CMV immune status, crucial for managing patients at risk of disease after organ and stem cell transplants.

Package insert for the T-SPOT.TB test
The T-SPOT.TB test is an in vitro diagnostic test for the detection of effector T cells that respond to stimulation by Mycobacterium tuberculosis antigens and is intended for use as an aid in the diagnosis of tuberculosis (TB) infection. The T-SPOT.TB test is a simplified enzyme-linked immunospot (ELISPOT) method which enumerates individual TB-specific activated effector T cells.

"Understanding your vaccine and immunotherapy efficacy"
Certimmune from Revvity provides tailored immunology services for vaccine and immunotherapy clinical trials, leveraging 20 years of expertise and global lab networks.

Oxford Diganostic Laboratories terms and conditions
The terms and conditions of service from Oxford Diagnostic Laboratories

A trusted partner for adaptive immunity testing for clinical trials
Certimmune’s global immunology services are brought to you by Revvity. Certimmune is built on the foundations of Revvity nearly 20 years experience developing more reliable, high throughput, standardized tests for measuring the adaptive immune system.

Auto-Pure 2400 for use with T-SPOT.TB: Efficient workflow, more time for you
The Auto-Pure 2400 can perform day 1 T-SPOT.TB workflows in under 3.5 hours with a single mid-run user interaction.

Uncover the Global Tuberculosis (TB) Landscape
Download our exclusive infographic on the global TB landscape. Explore key insights on diagnostics, prevention, and elimination strategies. Join the fight against TB.

Solutions for infectious disease research and discovery
Our diverse infectious disease research portfolio helps researchers make critical discoveries through genomic, protein, cell, and in vivo analysis.

Transforming preclinical leukemia research with no-wash immunoassays for BRD4-targeted degradation
This application note explores how HTRF based immunoassays enhance BRD4-targeted degradation studies, providing insights into leukemia research and accelerating drug discovery.

End-to-end metagenomics solutions.
By utilizing Next‑Generation Sequencing (NGS), entire communities within a sample can be efficiently analyzed from minimal quantities of DNA. Revvity and CosmosID® are now offering a comprehensive solution including reagents, automation, and analysis for your 16S data.


Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.